Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

ADMA Biologics IncTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: ADMA Biologics Inc is far larger — about 4.4× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.

ADMADNA
Market Cap
$2.22B$505.73M
Sector
HealthHealth
52-Week High
$20.38$16.14
52-Week Low
$7.60$5.48
Enterprise Value
$2.29B$607.68M

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA